Skip to main content

Table 1 Included publications from mainland China

From: Pathogen distribution in pulmonary infection in chinese patients with lung cancer: a systematic review and meta-analysis

Reference

Publication Year

No. examined

No. positive

No. Strains

No. gram-negative bacteria Strains

No. gram-positive bacteria Strains

No. fungi Strains

Therapeutic measures

Study design

Score

Aixian Hu [16]

2022

730

82

136

71

55

10

surgery

Cross sectional

3

Biao Xu [17]

2021

Ā 

246

309

189

91

29

surgery

Cross sectional

2

Fei Gao [18]

2022

358

32

49

31

15

3

surgery

Cross sectional

2

Ge Meng [19]

2022

114

34

49

34

13

2

chemotherapy

Cross sectional

3

Hongxiao Tuo [20]

2022

Ā 

100

108

66

32

10

surgery

Cross sectional

2

Hongyan Xu [21]

2022

Ā 

349

412

247

124

41

surgery

Cross sectional

1

Jianying Wang [22]

2022

Ā 

170

202

127

56

19

chemotherapy

Cross sectional

2

Jingxiang Yang [23]

2020

Ā 

120

206

158

16

32

chemotherapy

Cross sectional

3

Jun Zhu [24]

2017

Ā 

324

396

280

60

56

chemotherapy

Cross sectional

3

Miao Zhang [25]

2015

Ā 

65

103

79

8

16

chemotherapy

Cross sectional

1

Qiuhong Bao [26]

2019

411

184

204

84

32

36

chemotherapy

Cross sectional

3

Yanli Zhang [27]

2020

Ā 

136

151

106

26

19

chemotherapy

Cross sectional

3

Zewen Zhu [28]

2021

Ā 

159

202

114

56

32

chemotherapy

Cross sectional

2

Zhen Wang [29]

2021

250

25

37

27

9

1

surgery

Cross sectional

3

Zhihui Liu 30]

2021

124

103

119

65

19

35

chemotherapy

Cross sectional

2